Synfera is developing a shelf-stable, universally compatible oxygen therapeutic designed to reduce reliance on donated blood. By leveraging synthetic biology and recombinant biomanufacturing, we aim to create a scalable solution that addresses blood shortages, cold-chain limitations, and supply constraints. Our goal is to expand reliable oxygen delivery in emergency, rural, and resource-limited settings.

Global blood systems face critical shortages due to donor dependence, limited shelf life, and strict storage requirements. Synfera is advancing a biologically inspired oxygen-carrying protein that is naturally stable outside of cells, offering improved durability and extended storage compared to traditional hemoglobin-based approaches. Through precision fermentation and scalable production methods, we are building a next-generation platform for oxygen delivery that can strengthen healthcare resilience worldwide.